A major breakthrough in cancer investigation is occurring with the use of mini-antibodies to re-engage damaged p53. This vital tumor inhibitor protein is frequently disabled in various types of malignancies, resulting https://keybookmarks.com/story21969901/nanobodies-restore-tumor-suppressor-p53-a-potential-pathway-for-cancer-management